All Myocarditis, Pericarditis Cases With COVID-19 Vaccines Now Must Be Reported To VAERS
Executive Summary
The change to three vaccine emergency use authorizations was made quietly, most recently for the Novavax vaccine.
You may also be interested in...
Is A Class-Wide Myocarditis Warning Coming For COVID-19 Vaccines?
Now that multiple vaccines using different platforms seem to be associated with heart inflammation, the FDA and others want more data on whether a common characteristic of the virus or vaccine manufacturing is related.
Novavax Gains US FDA Advisory Committee Endorsement, But So Does Myocarditis Risk Statement
Vaccines and Related Biological Products Advisory Committee members agree another option should be made available, especially if Novavax's protein-based design could encourage those who refused the mRNA vaccines to be inoculated.
mRNA COVID Vaccine Dosing Intervals May Be Extended To Mitigate Myocarditis Risk
While data suggests higher risk of myocarditis in young males receiving Moderna’s vaccine, US CDC advisory committee did not consider preferential recommendation. ACIP voted to recommend Spikevax for those 18 years and older following full FDA approval.